StockNews.com initiated coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Get Rating) in a research note released on Thursday. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright upgraded shares of Onconova Therapeutics from a neutral rating to a buy rating and set a $11.00 target price for the company […]
StockNews.com began coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Get Rating) in a research note issued to investors on Wednesday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright raised Onconova Therapeutics from a neutral rating to a buy rating and set a $11.00 price target on the […]
Investment analysts at StockNews.com assumed coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Get Rating) in a report released on Wednesday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright upgraded shares of Onconova Therapeutics from a “neutral” rating to a “buy” rating and set a $11.00 price target on […]
StockNews.com assumed coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Get Rating) in a research report released on Monday. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright upgraded Onconova Therapeutics from a neutral rating to a buy rating and set a $11.00 price objective on the stock in a […]
Onconova Therapeutics, Inc. (NASDAQ:ONTX – Get Rating) was the recipient of a large drop in short interest in May. As of May 15th, there was short interest totalling 291,400 shares, a drop of 24.8% from the April 30th total of 387,400 shares. Based on an average daily volume of 540,800 shares, the days-to-cover ratio is […]